Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nivalis Therapeutics Inc (NASDAQ:NVLS)

14.32
Delayed Data
As of Sep 03
 -0.11 / -0.76%
Today’s Change
13.70
Today|||52-Week Range
20.43
--
Year-to-Date
No recent news for Nivalis Therapeutics Inc.

Today’s Trading

Previous close14.43
Today’s open14.59
Day’s range14.14 - 14.71
Volume37,305
Average volume (3 months)--
Market cap$223.0M
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)+10.08%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.15-2.83%
HSKAHeska Corp-1.52-4.41%
AKBAAkebia Therapeutics ...-0.95-12.62%
TBRATobira Therapeutics ...-0.42-3.43%
Data as of 09/03/2015

Financials

Next reporting dateDecember 2, 2015
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$0.00
Annual profit (last year)-$15.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon Congleton
Chief Operating Officer
Janice Troha
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers